Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) and Short Cytoplasmic Domain, (Semaphorin) 4A (Sema4a) Peptide
-
- Target See all Sema4a products
- Sema4a (Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) and Short Cytoplasmic Domain, (Semaphorin) 4A (Sema4a))
- Origin
- Human, Monkey
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-Semaphorin 4A Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- Sema4a (Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) and Short Cytoplasmic Domain, (Semaphorin) 4A (Sema4a))
- Synonyms
- SEMA4A Peptide, CORD10 Peptide, RP35 Peptide, SEMAB Peptide, SEMB Peptide, AI132332 Peptide, SemB Peptide, Semab Peptide, semaphorin 4A Peptide, sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A Peptide, SEMA4A Peptide, sema4a Peptide, Sema4a Peptide
- Background
- SEMAB, SEMB, Semaphorin-4A, Semaphorin-B, Sema B
- Gene ID
- 64218
- UniProt
- Q9H3S1
-